Lin Y - Search Results

1

Phase I and pharmacokinetic study of imatinib mesylate (Gleevec) and gemcitabine in patients with refractory solid tumors.

Ali Y, Lin Y, Gharibo MM, Gounder MK, Stein MN, Lagattuta TF, Egorin MJ, Rubin EH, Poplin EA. Ali Y, et al. Among authors: lin y. Clin Cancer Res. 2007 Oct 1;13(19):5876-82. doi: 10.1158/1078-0432.CCR-07-0883. Clin Cancer Res. 2007. PMID: 17908982 Clinical Trial.

2

Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma.

DiPaola RS, Chenven ES, Shih WJ, Lin Y, Amenta P, Goodin S, Shumate A, Capanna T, Cardiella M, Cummings KB, Aisner J, Todd MB. DiPaola RS, et al. Among authors: lin y. Cancer. 2001 Oct 15;92(8):2065-71. doi: 10.1002/1097-0142(20011015)92:8<2065::aid-cncr1546>3.0.co;2-k. Cancer. 2001. PMID: 11596021 Clinical Trial.

3

A phase I trial of a potent P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), administered orally in combination with doxorubicin in patients with advanced malignancies.

Rubin EH, de Alwis DP, Pouliquen I, Green L, Marder P, Lin Y, Musanti R, Grospe SL, Smith SL, Toppmeyer DL, Much J, Kane M, Chaudhary A, Jordan C, Burgess M, Slapak CA. Rubin EH, et al. Among authors: lin y. Clin Cancer Res. 2002 Dec;8(12):3710-7. Clin Cancer Res. 2002. PMID: 12473580 Clinical Trial.

4

Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.

Licitra EJ, Vyas V, Nelson K, Musanti R, Beers S, Thomas C, Poplin E, Smith S, Lin Y, Schaaf LJ, Aisner J, Gounder M, Rajendra R, Saleem A, Toppmeyer D, Rubin EH. Licitra EJ, et al. Among authors: lin y. Clin Cancer Res. 2003 May;9(5):1673-9. Clin Cancer Res. 2003. PMID: 12738720 Clinical Trial.

5

A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancy.

Toppmeyer DL, Gounder M, Much J, Musanti R, Vyas V, Medina M, Orlando T, Pennick M, Lin Y, Shih W, Goodin S, Rubin E. Toppmeyer DL, et al. Among authors: lin y. Med Sci Monit. 2003 Aug;9(8):PI99-104. Med Sci Monit. 2003. PMID: 12942041 Clinical Trial.

6

Development of a bioanalytical liquid chromatography method for quantitation of 9-nitrocamptothecin in human plasma.

Gounder MK, Sun SL, Sands H, Lin Y, Shih WJ, Gu Z, Charles-Williams S, Roychowdhury M, Rajendra R, Rubin EH. Gounder MK, et al. Among authors: lin y. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jan 5;799(1):63-72. doi: 10.1016/j.jchromb.2003.10.010. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 14659436

7

A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer.

Rao K, Goodin S, Levitt MJ, Dave N, Shih WJ, Lin Y, Capanna T, Doyle-Lindrud S, Juvidian P, DiPaola RS. Rao K, et al. Among authors: lin y. Prostate. 2005 Feb 1;62(2):115-22. doi: 10.1002/pros.20130. Prostate. 2005. PMID: 15389797 Clinical Trial.

8

A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies.

Schaar D, Goodell L, Aisner J, Cui XX, Han ZT, Chang R, Martin J, Grospe S, Dudek L, Riley J, Manago J, Lin Y, Rubin EH, Conney A, Strair RK. Schaar D, et al. Among authors: lin y. Cancer Chemother Pharmacol. 2006 Jun;57(6):789-95. doi: 10.1007/s00280-005-0125-1. Epub 2005 Oct 18. Cancer Chemother Pharmacol. 2006. PMID: 16231182 Clinical Trial.

9

Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.

Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, Garzotto M, Shih WJ, Lin Y, Lu SE, Rabson AB, Kong AN, Conney AH. Zheng X, et al. Among authors: lin y. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3444-51. doi: 10.1158/1078-0432.CCR-05-2823. Clin Cancer Res. 2006. PMID: 16740769

10

Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.

Zheng X, Cui XX, Avila GE, Huang MT, Liu Y, Patel J, Kong AN, Paulino R, Shih WJ, Lin Y, Rabson AB, Reddy BS, Conney AH. Zheng X, et al. Among authors: lin y. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5480-7. doi: 10.1158/1078-0432.CCR-07-0242. Clin Cancer Res. 2007. PMID: 17875778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49,350 results

Search Page